Wambolt & Associates LLC Sells 1,235 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Wambolt & Associates LLC cut its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 14.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 7,222 shares of the healthcare conglomerate's stock after selling 1,235 shares during the quarter. UnitedHealth Group makes up 1.2% of Wambolt & Associates LLC's portfolio, making the stock its 24th largest position. Wambolt & Associates LLC's holdings in UnitedHealth Group were worth $3,654,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at $25,000. AlphaMark Advisors LLC bought a new position in UnitedHealth Group in the fourth quarter valued at approximately $30,000. Promus Capital LLC bought a new stake in shares of UnitedHealth Group during the 4th quarter valued at $32,000. RPg Family Wealth Advisory LLC acquired a new stake in shares of UnitedHealth Group during the third quarter worth $37,000. Finally, Pillar Financial Advisors LLC acquired a new position in UnitedHealth Group in the fourth quarter valued at about $40,000. Institutional investors own 87.86% of the company's stock.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of the company's stock in a transaction dated Friday, January 17th. The stock was bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the acquisition, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. 0.33% of the stock is currently owned by insiders.

Remove Ads

Wall Street Analyst Weigh In

A number of analysts recently weighed in on UNH shares. Barclays cut their price target on shares of UnitedHealth Group from $655.00 to $642.00 and set an "overweight" rating on the stock in a research report on Friday, January 17th. Deutsche Bank Aktiengesellschaft boosted their price target on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a "buy" rating in a report on Tuesday, December 3rd. HSBC upgraded UnitedHealth Group from a "hold" rating to a "buy" rating and set a $595.00 price target for the company in a report on Friday, January 10th. Oppenheimer lifted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research note on Friday, December 6th. Finally, Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of "Buy" and an average price target of $629.32.

UnitedHealth Group Stock Performance

Shares of UnitedHealth Group stock traded up $1.23 during trading on Friday, hitting $516.95. 1,371,059 shares of the stock were exchanged, compared to its average volume of 4,775,114. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $472.86 billion, a price-to-earnings ratio of 33.38, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a fifty day moving average price of $508.70 and a 200-day moving average price of $545.16.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts' consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the firm earned $5.83 EPS. The firm's revenue was up 6.8% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. The ex-dividend date was Monday, March 10th. UnitedHealth Group's dividend payout ratio is presently 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.